82 related articles for article (PubMed ID: 12200710)
21. Effect of priming with granulocyte colony-stimulating factor on the outcome of chemotherapy for acute myeloid leukemia.
Löwenberg B; van Putten W; Theobald M; Gmür J; Verdonck L; Sonneveld P; Fey M; Schouten H; de Greef G; Ferrant A; Kovacsovics T; Gratwohl A; Daenen S; Huijgens P; Boogaerts M; ;
N Engl J Med; 2003 Aug; 349(8):743-52. PubMed ID: 12930926
[TBL] [Abstract][Full Text] [Related]
22. Successful treatment of childhood hypocellular acute myeloid leukemia.
Yamamoto M; Hori T; Hatakeyama N; Igarashi K; Iesato K; Nakanishi K; Noguchi H; Miyachi H; Ito M; Tsutsumi H; Suzuki N
J Pediatr Hematol Oncol; 2012 Jul; 34(5):398-401. PubMed ID: 22278198
[TBL] [Abstract][Full Text] [Related]
23. Clinical effect of granulocyte colony-stimulating factor on neutrophils and leukemic cells in myelogenous leukemia: analysis.
Ishikawa J; Yoshimura M; Matsunashi T; Tominaga N; Teshima H; Hiraoka A; Nakamura H; Shibata H; Masaoka T; Takaku F
Jpn J Clin Oncol; 1991 Jun; 21(3):169-75. PubMed ID: 1719259
[TBL] [Abstract][Full Text] [Related]
24. Multidrug resistance expression and proliferative studies in poor risk acute myeloid leukemia treated with the FLAG (G-CSF plus fludarabine and Ara-C) regimen.
Tafuri A; De Felice L; Petrucci MT; Mascolo MG; Ricciardi MR; Ciliberti C; Martelli MP; Petti MC
Cytokines Mol Ther; 1995 Dec; 1(4):301-7. PubMed ID: 9384683
[TBL] [Abstract][Full Text] [Related]
25. Production of granulocyte colony stimulating factor, granulocyte macrophage colony stimulating factor, and tumor necrosis factor alpha during remission and infections in patients with acute leukemia.
Duru F; Ertem U; Taçyildiz N; Kirazli S
J Med; 1995; 26(5-6):241-52. PubMed ID: 8721901
[TBL] [Abstract][Full Text] [Related]
26. Acute myeloid leukemia or myelodysplastic syndrome following use of granulocyte colony-stimulating factors during breast cancer adjuvant chemotherapy.
Hershman D; Neugut AI; Jacobson JS; Wang J; Tsai WY; McBride R; Bennett CL; Grann VR
J Natl Cancer Inst; 2007 Feb; 99(3):196-205. PubMed ID: 17284714
[TBL] [Abstract][Full Text] [Related]
27. New perspectives in the treatment of acute myeloid leukemia by hematopoietic growth factors.
Hiddemann W; Wörmann B; Reuter C; Schleyer E; Zühlsdorf M; Böckmann A; Büchner T
Semin Oncol; 1994 Dec; 21(6 Suppl 16):33-8. PubMed ID: 7528449
[TBL] [Abstract][Full Text] [Related]
28. High percentage of CD34-positive cells in autologous AML peripheral blood stem cell products reflects inadequate in vivo purging and low chemotherapeutic toxicity in a subgroup of patients with poor clinical outcome.
Feller N; Schuurhuis GJ; van der Pol MA; Westra G; Weijers GW; van Stijn A; Huijgens PC; Ossenkoppele GJ
Leukemia; 2003 Jan; 17(1):68-75. PubMed ID: 12529662
[TBL] [Abstract][Full Text] [Related]
29. Transient atypical monocytosis mimic acute myelomonocytic leukemia in post-chemotherapy patients receiving G-CSF: report of two cases.
Liu CZ; Persad R; Inghirami G; Sen F; Amorosi E; Goldenberg A; Ibrahim S
Clin Lab Haematol; 2004 Oct; 26(5):359-62. PubMed ID: 15485468
[TBL] [Abstract][Full Text] [Related]
30. Recombinant human glycosylated granulocyte colony-stimulating factor (rhG-CSF)-combined regimen for allogeneic bone marrow transplantation in refractory acute myeloid leukemia.
Takahashi S; Okamoto SI; Shirafuji N; Ikebuchi K; Tani K; Shimane M; Matsudaira T; Irie S; Tsuruta T; Matsuishi E
Bone Marrow Transplant; 1994 Mar; 13(3):239-45. PubMed ID: 7515298
[TBL] [Abstract][Full Text] [Related]
31. Less toxicity by optimizing chemotherapy, but not by addition of granulocyte colony-stimulating factor in children and adolescents with acute myeloid leukemia: results of AML-BFM 98.
Creutzig U; Zimmermann M; Lehrnbecher T; Graf N; Hermann J; Niemeyer CM; Reiter A; Ritter J; Dworzak M; Stary J; Reinhardt D
J Clin Oncol; 2006 Sep; 24(27):4499-506. PubMed ID: 16983120
[TBL] [Abstract][Full Text] [Related]
32. Increase of erythropoiesis and thrombopoiesis, and induction of remission by granulocyte colony-stimulating factor (G-CSF) in a patient with hypoplastic leukemia.
Yanagisawa K; Yano A; Takada K; Yasukawa M; Fujita S
Leukemia; 1994 Jul; 8(7):1249-51. PubMed ID: 7518552
[No Abstract] [Full Text] [Related]
33. High remission rate, short remission duration in patients with refractory anemia with excess blasts (RAEB) in transformation (RAEB-t) given acute myelogenous leukemia (AML)-type chemotherapy in combination with granulocyte-CSF (G-CSF).
Estey EH; Kantarjian HM; O'Brien S; Kornblau S; Andreeff M; Beran M; Pierce S; Keating M
Cytokines Mol Ther; 1995 Mar; 1(1):21-8. PubMed ID: 9384660
[TBL] [Abstract][Full Text] [Related]
34. A multicenter, open, noncomparative, phase II study of the combination of cladribine (2-chlorodeoxyadenosine), cytarabine, granulocyte colony-stimulating factor and mitoxantrone as induction therapy in refractory acute myeloid leukemia: a report of the Polish Adult Leukemia Group.
Wrzesień-Kuś A; Robak T; Wierzbowska A; Lech-Marańda E; Pluta A; Wawrzyniak E; Krawczyńska A; Kuliczkowski K; Mazur G; Kiebiński M; Dmoszyńska A; Wach M; Hellmann A; Baran W; Hołowiecki J; Kyrcz-Krzemień S; Grosicki S;
Ann Hematol; 2005 Sep; 84(9):557-64. PubMed ID: 15856358
[TBL] [Abstract][Full Text] [Related]
35. A randomized controlled study of granulocyte colony stimulating factor after intensive induction and consolidation therapy in patients with acute lymphoblastic leukemia. Japan Adult Leukemia Study Group.
Ohno R; Tomonaga M; Ohshima T; Masaoka T; Asou N; Oh H; Nishikawa K; Kanamaru A; Murakami H; Furusawa S
Int J Hematol; 1993 Aug; 58(1-2):73-81. PubMed ID: 7693029
[TBL] [Abstract][Full Text] [Related]
36. Non-anthracycline based remission induction therapy for newly diagnosed patients with acute myeloid leukemia aged 60 or older.
Bashey A; Liu L; Ihasz A; Medina B; Corringham S; Keese K; Carrier E; Castro JE; Holman P; Lane TA; Hassidim K; Ball ED
Leuk Res; 2006 Apr; 30(4):503-6. PubMed ID: 16303178
[TBL] [Abstract][Full Text] [Related]
37. Complete remission in acute myeloid leukaemia with t(8;21) following treatment with G-CSF: flow cytometric analysis of in vivo and in vitro effects on cell maturation.
Ferrara F; Di Noto R; Viola A; Russo C; Boccuni P; Costantini S; Dello Russo A; Lo Pardo C; Del Vecchio L
Br J Haematol; 1999 Aug; 106(2):520-3. PubMed ID: 10460615
[TBL] [Abstract][Full Text] [Related]
38. [Management of anemia and bone marrow hypoplasia in the treatment of myeloid leukemia].
Yokoyama H; Harigae H
Nihon Rinsho; 2009 Oct; 67(10):1974-7. PubMed ID: 19860200
[TBL] [Abstract][Full Text] [Related]
39. Complete remission in acute myeloid leukaemia after treatment with recombinant human granulocyte colony-stimulating factor and high dose intravenous methylprednisolone.
Sugawara T; Sato A; Shishido T; Okuda M; Kameoka J; Meguro K; Endo K; Yoshinaga K
Br J Haematol; 1991 Apr; 77(4):561-2. PubMed ID: 1709041
[No Abstract] [Full Text] [Related]
40. [Supportive therapies for myeloid leukemia including blood transfusion and growth factors].
Yao H; Ashihara E; Maekawa T
Nihon Rinsho; 2009 Oct; 67(10):1951-7. PubMed ID: 19860196
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
